SCHEMBL19934809

SCHEMBL19934809

COC(=O)c1cc(OC)cc2oc(-c3ccccc3)c(-c3cc(OC)cc(OC)c3)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.48
▸ MAPT P10636 5/20 0.44
▸ CYP3A4 P08684 3/20 0.44
▸ TSHR P16473 3/20 0.44
▸ ABCG2 Q9UNQ0 3/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ ABCB1 P08183 2/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ CCNC P24863 1/20 0.43
▸ CDK8 P49336 1/20 0.43
▸ KDM4E B2RXH2 7/20 0.43
▸ ALDH1A1 P00352 6/20 0.43
▸ HPGD P15428 5/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19934782 0.92 ALDH1A1 (0.51) ADORA3MAPTCYP3A4ABCG2NPC1
SCHEMBL19929840 0.89 L3MBTL1 (0.44) ADORA3MAPTCYP3A4TSHRABCG2
SCHEMBL19934810 0.87 KDM4E (0.48) ADORA3MAPTCYP3A4TSHRABCG2
SCHEMBL28654877 0.85 ADORA3 (0.52) ADORA3MAPTCYP3A4TSHRABCG2
SCHEMBL30022955 0.83 KDM4E (0.50) ADORA3MAPTCYP3A4ABCG2NPC1
SCHEMBL28654875 0.83 KDM4E (0.50) ADORA3MAPTCYP3A4ABCG2NPC1
SCHEMBL30081087 0.81 L3MBTL1 (0.46) ADORA3MAPTCYP3A4TSHRABCG2
SCHEMBL28873071 0.81 L3MBTL1 (0.46) ADORA3MAPTCYP3A4TSHRABCG2
SCHEMBL30081099 0.81 MAPT (0.47) ADORA3MAPTABCG2NPC1ABCB1
SCHEMBL28873070 0.81 MAPT (0.47) ADORA3MAPTABCG2NPC1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-12-17 — — US disclosed
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HPGDS, DPP7, DPEP1 ADORA3 1983/4885MAPT 4251/4885CYP3A4 717/4885
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them HPGDS, DPP7, DPEP1 ADORA3 1983/4885MAPT 4251/4885CYP3A4 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback